Literature DB >> 6664356

[Prader-Labhart-Willi syndrome].

W H Fesseler, J R Bierich.   

Abstract

12 patients (9 male, 3 female) with the Prader-Labhart-Willi-Syndrome (PLWS) were examined, and had medical treatment. Small stature varied in degree; body-height was found below the 25th percentile of normal height in 9 of the patients, 6 of them ranged along or below the 3rd percentile. Growth-hormone (GH) was measured after i.v.-Arginine-provocationtest; in 7 cases GH-peaks did not rise over 10 ng/ml, 4 of the children showed GH-peaks of less than 4 ng/ml. One of the boys was treated with GH for 5 years with good results, no secondary effect on carbohydrate metabolism was observed. In one girl we started with GH-therapy only recently. In 7 of 9 children at the age of puberty we found hypogonadotrophic hypogonadism. In 10 patients, who underwent i.v. GTT, 4 showed a prediabetic metabolic state with elevated plasma insulin levels, a fifth boy suffered from diabetes. The development of type-2-diabetes is caused by abnormal insulin-resistance, which is connected with overfeeding and obesity. Treatment of obesity is the most important problem in the PLWS. Regular hypocaloric food is not accepted by most of the children. Therefore, in cases of ineffective dietetic treatment, we recommend gastric partitioning with proximal gastro-jejunostomy, as we performed in two of our patients with good results regarding weight-loss. In two of six children examined, we found chromosomal abnormalities.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6664356

Source DB:  PubMed          Journal:  Monatsschr Kinderheilkd        ISSN: 0026-9298            Impact factor:   0.323


  3 in total

1.  Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance.

Authors:  U Eiholzer; R Gisin; C Weinmann; S Kriemler; H Steinert; T Torresani; M Zachmann; A Prader
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

2.  Growth hormone secretion in Prader-Willi syndrome.

Authors:  S Grosso; M Cioni; S Buoni; L Peruzzi; L Pucci; R Berardi
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

3.  Prader-Willi syndrome: current understanding of cause and diagnosis.

Authors:  M G Butler
Journal:  Am J Med Genet       Date:  1990-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.